US2021363289A1PendingUtilityA1

Resin compositions and resin infusion process

Assignee: CYTEC IND INCPriority: Oct 26, 2017Filed: Aug 3, 2021Published: Nov 25, 2021
Est. expiryOct 26, 2037(~11.2 yrs left)· nominal 20-yr term from priority
C08L 63/04C08G 59/26C08G 59/188C08L 9/06C08G 59/3218C08G 59/38C08G 59/226C08L 63/00C08G 59/5033B29C 70/48C08G 2120/00C08L 2207/53C08L 21/00
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Curable epoxy resin compositions suitable for liquid resin infusion processes. In one embodiment, the resin composition contains (a) at least two polyepoxides, one of which is triglycidyl ether of tris(hydroxyphenyl)methane, (b) an aromatic amine curing agent, and (c) core-shell rubber particles. In another embodiment, the resin composition (a) at least two polyepoxides, one of which is diglycidyl ether of bis(hydroxyphenyl)fluorene, (b) an aromatic amine curing agent, and (c) core-shell rubber particles.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A curable epoxy resin composition suitable for liquid resin infusion, comprising:
 (A) only two polyepoxides, one of which is diglycidyl ether of bis(hydroxyphenyl)fluorene represented by Formula IV:   
       
         
           
           
               
               
           
         
       
       and the other polyepoxide is a naphthalene-based epoxy having at least one naphthalene ring in its formula;
 (B) an aromatic amine curing agent selected from 9,9-bis(3-chloro-4-aminophenyl) fluorene (CAF) and 9,9-bis(4-aminophenyl)fluorene 
 (C) core-shell rubber particles. 
 
     
     
         14 . The curable epoxy resin composition of  claim 13 , wherein naphthalene-based epoxy is selected from: diglycidyl ether of 1,6-dihydroxy naphthalene; 1,7-dihydroxy naphthalene; 1 naphthalene cresol glycidyl ether; 1,2-dihydroxynaphthalene; 1,3-dihydroxynaphthalene; 1,4-dihydroxynaphthalene; 1,5-dihydroxynaphthalene; 2,3-dihydroxynaphthalene; 2,7-dihydroxynaphthalene; and combination thereof. 
     
     
         15 . The curable epoxy resin composition of  claim 13 , wherein naphthalene-based epoxy is present in an amount greater than 0% and up to 30% by weight based on the total weight of the composition. 
     
     
         16 - 18 . (canceled) 
     
     
         19 . A liquid resin infusion (LRI) manufacturing method for producing a molded article, comprising the steps of providing a fibrous preform configured to receive liquid resin, infusing the fibrous preform with the curable epoxy resin composition of  claim 13 , and curing the resin-infused preform at a curing temperature (T c ). 
     
     
         20 . The method of  claim 19 , further comprising:
 a. placing the fibrous preform in a closed mold;   b. heating the mold to an initial temperature;   c. injecting the curable epoxy resin composition into the mold so as to infuse the fibrous preform with the epoxy resin composition; and   d. curing the resin-infused preform at the curing temperature (T c ), which is higher than the initial temperature, for a time period sufficient to form a hardened article.

Join the waitlist — get patent alerts

Track US2021363289A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.